Peg-Intron PEG-interferon alfa-2b regulatory update

ENZN partner Schering-Plough Corp. (Madison, N.J.) submitted an MAA for European marketing approval of Peg-Intron to treat chronic hepatitis C in adults with compensated liver disease. Peg-Intron, a ...